Pretranslational and posttranslational regulation of the EGF receptor during the prereplicative phase of liver regeneration
- 1 September 1990
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 12 (3) , 533-541
- https://doi.org/10.1002/hep.1840120314
Abstract
We studied the regulation of the epidermal growth factor receptor mRNA and the number of epidermal growth factor binding sites in subcellular compartments involved in the biosynthesis and endocytosis of the epidermal growth factor receptor during the prereplicative phase of liver regeneration. The epidermal growth factor receptor mRNA, quantified by solution hybridization, decreased after partial hepatectomy, with a nadir of about 35% 18 hr after hepatectomy. An even strongèr decrease in the number of epidermal growth factor binding sites after partial hepatectomy was observed in a Golgi-enriched low-density membrane fraction, reflecting available newly synthesized epidermal growth factor receptors. It is suggested that this decrease in newly synthesized available epidermal growth factor receptors is caused primarily, but not entirely, by decreased epidermal growth factor receptor mRNA levels and the additional downregulation of epidermal growth factor binding sites may involve posttranslational mechanisms such as intracellular occupation by transforming growth factor-α. The observation that the number of specific epidermal growth factor binding sites after partial hepatectomy was only moderately reduced in prelysosomal endosomes and in lysosomes, compared with the newly synthesized receptors, may indicate that a pool of receptors targeted for lysosomes exists and these receptors are regulated in a different manner than the receptor pool targeted for the cell surface. Furthermore, at least two separable endocytic subcompartments are involved in the transport of the epidermal growth factor/epidermal growth factor receptor complex in the liver. The complex first enters early endosomes, then enters late, prelysosomal endosomes, where the epidermal growth factor is proteolytically processed, before arriving in the lysosomal compartment. (Hepatology 1990;12:533-541).This publication has 68 references indexed in Scilit:
- Biological effects of epidermal growth factor, with emphasis on the gastrointestinal tract and liver: An updateHepatology, 1989
- The epidermal growth factor receptor as a multifunctional allosteric proteinBiochemistry, 1988
- RECEPTORS FOR EPIDERMAL GROWTH FACTOR AND OTHER POLYPEPTIDE MITOGENSAnnual Review of Biochemistry, 1987
- Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptorBiochemistry, 1987
- Self-phosphorylation of epidermal growth factor receptor: evidence for a model of intermolecular allosteric activationBiochemistry, 1987
- Receptor-mediated endocytosis of epidermal growth factor by rat hepatocytes: receptor pathway.The Journal of cell biology, 1986
- DNA synthesis in rat hepatocytes: Inhibition by a platelet factor and stimulation by an endogenous factorJournal of Cellular Physiology, 1985
- Receptor-mediated endocytosis of epidermal growth factor by hepatocytes in the perfused rat liver: ligand and receptor dynamics.The Journal of cell biology, 1984
- Circadian Stage-Dependent Effects of Epidermal Growth Factor on Deoxyribonucleic Acid Synthesis in Ten Different Organs of the Adult Male Mouse*Endocrinology, 1981
- Hormonal stimulation of DNA synthesis in primary cultures of adult rat hepatocytes.Proceedings of the National Academy of Sciences, 1976